 |
Ancrod |
|---|---|
| Trade Name | Viprinex |
| Orphan Indication | To establish and maintain anticoagulation in heparin-intolerant patients undergoing cardiopulmonary bypass |
| USA Market Approval | USA |
| USA Designation Date | 1989-10-20 00:00:00 |
| Sponsor | Knoll Pharmaceutical Company;3000 Continental Dr., North;Mt. Olive, New Jersey, 07828 |
